The market size of contraceptives (based on hormones or spermicides) in New Zealand has demonstrated a varied trend from 2013 to 2023, with fluctuating year-on-year values. Noteworthy events include a significant peak in 2017 followed by a steady recovery phase until 2023. In 2023, the market value stood at 28.129 million US dollars. The average annual growth rate (CAGR) over the last five years is 3.2%, suggesting a gradual but steady market expansion.
Future trends to watch for:
- Technological advancements and their impact on contraceptive methods.
- Incorporation of digital healthcare solutions within contraceptive markets.
- Potential influence of changing governmental policies on market dynamics.
- Evolving consumer preferences for non-hormonal alternatives or natural contraceptives.
How does New Zealand rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 8 | 8 Switzerland | 62,127,000 | 2023 | -5.57% | -3.62% | View data |
| 9 | 9 Ukraine | 42,988,000 | 2023 | -0.81% | -0.71% | View data |
| 10 | 10 New Zealand | 28,129,000 | 2023 | +2.59% | +3.2% | |
| 11 | 11 Guatemala | 20,869,000 | 2023 | -9.52% | -9.55% | View data |
| 12 | 12 France | 16,955,000 | 2023 | -61.67% | -36.31% | View data |
